Distinct Clinical and Biological Features of Diffusely Metastatic Versus Bulky Localized Lung Cancer: Real-World Outcomes from a University Cancer Center in Germany

Guardado en:

Detalles Bibliográficos
Publicado en:	Cancers vol. 17, no. 23 (2025), p. 3728-3744
Autor principal:	Resuli Blerina
Otros Autores:	Walter, Julia, Kauffmann-Guerrero, Diego, Behr Jürgen, Arnold, Paola, Götschke Jeremias, Leuschner Gabriela, Kovács, Julia, Eze Chukwuka, Schneider, Christian, Tufman Amanda
Publicado:	MDPI AG
Materias:	Patients Histology Medical prognosis Metastasis Regression analysis Lung cancer Immunotherapy Age Cancer therapies Mutation Adenocarcinoma Biomarkers Tumors Biology Metastases Radiation therapy Chemotherapy Statistical analysis
Acceso en línea:	Citation/Abstract Full Text + Graphics Full Text - PDF
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Descripción
Resumen:	Background: Lung cancer metastasis results from local invasion, loss of adhesion, migration, and distant implantation. Some small tumors metastasize diffusely other tumors progress to local bulky disease without metastasis. Here we compare these biologically divergent courses of progression and present an analysis of clinical features related to early diffuse metastasis vs. bulky disease. Methods: We retrospectively collected data from pathologically confirmed not-metastatic “bulky” (cT3-T4cN0cM0) or “diffusely metastatic” (cT1-T2cN1-3cM1) patients with lung cancer treated at our center from 2013 to 2023. Clinical data including sex, age, histology, ECOG-PS, tumor stage, smoking status, presence, and site of metastases, LDH, CRP, NLR ratio were collected. Results: A total of 375 patents with “bulky” (n = 95) or diffusely metastatic lung cancer (n = 280) were included in the analysis. In the univariate analysis, the diffusely metastatic population was younger (p = 0.001), had a higher proportion of never smokers (p = 0.02), histologically adenocarcinoma (p < 0.0001), TTF1 positive (p < 0.00001) and elevated baseline LDH in serum (LDH > 250U/l, p < 0.0001) compared to “bulky” population. Patients with diffuse metastatic disease presented worse OS (HR = 2.34, p = 0.0001) and PFS (HR = 6.89, p < 0.0001) compared to patients with bulky disease. Conclusions: Younger age, never smokers, TTF1 positivity, poorly differentiated tumors, adenocarcinoma histology were independently associated with risk of distant metastasis.
ISSN:	2072-6694
DOI:	10.3390/cancers17233728
Fuente:	Biological Science Database